(Q38871356)

7 September 2017

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART. (English)

1 reference

7 September 2017

0 references

Charles F Gilks

9

0 references

Cissy Kityo

4

object named as

Cissy Kityo

1 reference

7 September 2017

8

Francis Ssali

1 reference

7 September 2017

3

Ann Sarah Walker

1 reference

7 September 2017

1

Paula Munderi

1 reference

7 September 2017

11

DART Trial Team

1 reference

7 September 2017

7

Navdeep K Thoofer

1 reference

7 September 2017

Wendy B Snowden

2

1 reference

7 September 2017

Michael Mosteller

5

1 reference

7 September 2017

Geoffrey Kabuye

6

1 reference

7 September 2017

Arlene R Hughes

10

1 reference

7 September 2017

23 November 2010

1 reference

Tropical Medicine and International Health

7 September 2017

1 reference

7 September 2017

16

1 reference

7 September 2017

2

1 reference

7 September 2017

200-204

1 reference

Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci

7 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

New allele frequency database: http://www.allelefrequencies.net

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02688.X

10.1111/J.1365-3156.2010.02688.X

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference